There is a growing body of evidence suggesting that vagal afferents play a major role in peripheralneural communication. This study was undertaken to determine whether a dose-dependent effect of lipopolysaccharide (LPS) on vagotomy-induced febrile unresponsiveness exists, and to examine the effect of vagotomy on LPS-induced increase in hypothalamic prostaglandin E 2 (HT PGE 2 ) production. Vagotomized and sham-operated rats were subjected to two experimental protocols. In the first, vagotomized and sham-operated rats were injected intraperitonealy with different doses of LPS (200, 500 and 1000 µg/kg) in order to examine the dose-dependent effect of LPS on the biphasic febrile response of the rats. In the second protocol, vagotomized and sham-operated rats were injected intraperitonealy with LPS (500 µg/kg). Two hours post injection, body temperature was measured, the rats were decapitated and blood was collected. Simultaneously, the rats' hypothalami were excised and incubated for 1 h in a Krebs-Henseleit buffer. Next, HT PGE 2 was determined by radioimmunoassay. Vagotomy-induced gastric enlargement was then measured to examine the correlation between the magnitude of the enlargement and that of the vagotomy-related febrile unresponsiveness. It was found that vagotomized-induced febrile unresponsiveness is a dose-dependent effect. Subdiaphragmatic resection of the vagus prevented the biphasic febrile response caused by the lowest dose (200 µg/kg) of LPS, whereas the highest dose of LPS (1000 µg/kg) caused a similar biphasic febrile response in both vagotomized and sham-operated rats. Indeed, vagotomy attenuates LPS-induced increase in HT PGE 2 , and blocks the hypothermic phase of the febrile response. On the other hand, no correlation between gastric enlargement and febrile unresponsiveness was found. The results of the present study may cast further light on the crucial role of the vagus nerve as a peripheral-neural pathway in the mediation of the febrile response.
INTRODUCTION
Peripheral administration of a pyrogen such as LPS induces several brain-related changes including fever, sickness behavior and loss of appetite. 1 In our previous studies, we demonstrated that intraperitoneal (i.p.) injection of LPS in rats causes a short-term fall in body temperature (hypothermia), followed by a body temperature elevation. 2 However, it is not well understood how this pyrogen and the cytokines it induces reach the brain. Some plausible explanations have been suggested, including passage into the brain by active transport through the blood brain barrier (BBB), passage via leaky regions of the BBB and the possibility that pyrogens may activate peripheral sensory nerves that signal the brain. 3 In recent years, a growing body of evidence suggesting a major role for the vagal afferents in peripheral-central (brain) communication has accumulated. [3] [4] [5] [6] Vagotomy appears to attenuate the febrile response to peripheral administered pyrogen. The vagal mediation of the febrile response seems to be pyrogen dose-dependent. 4 Vagotomy has no marked effect on circulating endotoxin or blood interleukin (IL)-1β, IL-6, and corticosterone levels, after systemic (i.p.) LPS administration. 7 Hyperthermia, induced by a peripheral pyrogen, is associated with an increase in PGE 2 production in the hypothalamus. 2 For many years, it has been assumed that the pre-optic anterior hypothalamus (POAH), is the presumptive primary locus of the thermoregulatory center. 8, 9 Increase in HT PGE 2 production is a primary event in the mechanism of fever. 2, 3, 10 The role of the vagus nerve in the mediation of fever development was confirmed when PGE 2 (as a pyrogenic stimulus) was injected intracerebroventricularly to vagotomized rats. In either a low or a high dose, vagotomized rats responded to it with the same hyperthermia as their sham-operated counterpart. 11 In a study examining the effect of subdiaphragmatic vagotomy on central levels of PGE 2 (as measured in the extracellular fluid of the POAH, collected by microdialysis) in guinea pigs treated with intravenous 2 µg/kg of LPS, it was demonstrated that vagotomy blocked the increase in pre-optic PGE 2 levels in the collected fluid, as compared to the sham-operated animals. 5 The main objective of the present study was to examine the association between the dosage of the pyrogen (LPS) and febrile unresponsiveness induced by vagotomy. We also examined the effect of vagotomy on the LPS-induced increase in HT PGE 2 production, via a direct measurement of PGE 2 in the hypothalamic tissue, as described in our previous studies. 2, 12 
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats, weighing 190-210 g, obtained from Harlan Laboratories (Rehovot, Israel), were used throughout the study. The animals were maintained under controlled environmental conditions (ambient temperature of 22 ± 1°C, relative humidity of 45-55%, photoperiod cycle of 12 hours light:12 hours dark, with light on at 0600), fed Purina Lab Chow and water ad libitum.
Surgical procedure
Twelve hours before the surgical procedure, the rats were deprived of food and water. Thereafter, they were anaesthetized with ketamine (70 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.). Next, they were subjected to one of two surgical procedures. In the first group, rats underwent a total subdiaphragmatic vagotomy (TSV). Laparatomy was performed by transversal incision; the anterior, posterior and hepatic branches of the vagus were identified and then transected. In the second group, rats underwent a sham-surgery. Laparatomy was performed, the anterior, posterior and hepatic branches of the vagus were identified but not transected. In both groups, the incisions were closed following surgery. All animals were kept under special post-surgical care for 2 days. At the end of a 4 week recovery period, only animals with no overt pathology were included in the study.
Vagotomy verification
Completeness of vagotomy was assessed using the food intake analysis test, based on the satiety effect of cholecystokinin (CCK), which is known to be mediated by the vagus nerve. 13 Four weeks post-surgery, the rats were adapted to a glucose solution (0.125 g/ml). During the first week, rats were deprived of food and water for 6 h every day, and then given access to the glucose solution for 1 h. Volumes consumed were measured at the end of the exposure. Thereafter, fresh food and water were offered to the animals. Following a week of accustomisation, the first test day was undertaken. Rats were individually housed and deprived of food and water (for 20 h and 6 h before injection, respectively). Then, 5 min before being given access to the glucose solution, the animals were injected with saline (0.5 ml/rat, i.p.) or CCK 4 µg/kg (CCK, Pancreozymin, P-4429, Lot 125H1002, Sigma). The glucose solution was made available to the animals for 1 h, and the volumes consumed were measured. On this day, one-half of the TSV and sham-operated animals received CCK. On the next test day (performed 3 days later), saline and CCK treatments were reversed. For every animal, every CCK test day had a corresponding saline day. When the CCK injection did not lead to a significant decrease in glucose (solution) consumption, the surgical procedure was considered successful. On the other hand, in the sham-operated group, when the CCK injection was not accompanied by decreased glucose consumption, the animal was excluded.
Body temperature and weight measurement
Body temperature was measured with a plastic-coated thermocouple (type K) probe (HL 600 Thermometer Anritherm, Anristu Meter Co., Japan) inserted 5 cm into the rectum. The rats were accustomised to this procedure 6 weeks before the experimental protocol was performed. In the post-surgical recovery period, body temperature was measured twice a day, every second day. Body weight was measured every second day.
Experimental protocols
Protocol A The first experimental protocol included three experimental designs. The first included: (i) a TSV group (n = 8) which was injected intraperitonealy with LPS 200 µg/kg (LPS from Escherichia coli L4130, Lot 69H4157, Sigma); (ii) a sham-operated group (n = 8) which was treated with LPS 200 µg/kg (i.p.); and (iii) a control group (sham-operated, n = 6) which was treated with a vehicle (0.5 ml saline, i.p.). Body temperature was measured at 0, 2, and 24 h after LPS/vehicle injection. The rats were then killed with CO 2 and their stomachs were removed, cleaned and weighed. In the second and third designs, the same process was performed, but the experimental (TSV and sham-operated groups, n = 6) received higher doses of LPS (500 µg/kg and 1000 µg/kg, respectively), and their stomachs were not weighed.
Protocol B
In the second experimental protocol, the TSV and shamoperated animals were accustomised to body temperature measurement during the recovery period as mentioned above. This protocol included four groups. The first (TSV, n = 6) and second (sham-operated, n = 6) groups were treated with LPS 500 µg/kg (i.p.). The third (TSV, n = 5) and fourth (sham-operated, n = 5) groups were injected (i.p.) with 0.5 ml of sterile saline. Body temperature was measured before (time 0) and 2 h after LPS administration. Next, the rats were decapitated, trunk blood was collected immediately in heparin-coated tubes and centrifuged at 1800 rpm for 10 min, for plasma separation. Plasma samples were separated and kept at -20°C, for cytokine determination. Simultaneous to the blood collection, the hypothalami were quickly excised and cleaned of blood and adipose tissue. The hypothalami were then cultured for 1 h at 37°C in a vial containing 1 ml of Krebs-Henseleit solution (0.2% glucose) in an environment of 95% O 2 and 5% CO 2 adjusted to pH 7.35-7.40. At the end of incubation, the medium was collected from each vial. The weight of each hypothalamus was measured after drying on a filter paper. The samples were kept at -20°C until HT PGE 2 determination.
Determination of HT PGE 2
PGE 2 determination was made by a single antibody radioimmunoassay (RIA) with dextran-coated charcoal. PGE 2 for the standard curve and rabbit antisera to PGE 2 were purchased from Sigma. [ 3 H]-PGE 2 (160 Ci/mmol) was obtained from Radiochemical Center (Amersham, UK). The sensitivity of the assay was 0.15 ng/ml. The RIA was performed in duplicate for each sample. Crossreactivity of the PGE 2 antiserum at 50% displacement to other PGs was as follows: PGA 1 = 3%, PGA 2 = 1.2%, PGF 1 α = 7.7% and PGF 2 α = 6.8%. The content of PGE 2 in individual incubation medium samples, obtained by RIA, was then plotted per weight of hypothalamus.
Statistical analysis
Results are expressed as mean ± SEM. Statistical evaluation was carried out using functional analysis (ANOVA) and Student's t-test (two-tailed), to test for differences between the control and experimental groups. Values of P <0.05 were considered statistically significant.
RESULTS
Dose-dependent effect of LPS on body temperature of vagotomized and sham-operated rats
Three experimental designs were used to elucidate the dose-dependent effect of LPS on febrile response in vagotomized rats. In the first design, TSV and sham-operated animals were treated with LPS 200 µg/kg (i.p.), while the control (sham-operated) group was treated with saline. It was found that subdiaphragmatic resection of the vagus prevents LPS-induced biphasic febrile response (Fig. 1A) . Vagotomy prevents the hypothermic and hyperthermic responses to LPS. In the second design, LPS was given in a higher dose (500 µg/kg). It was found that vagotomy prevents the hypothermic response to LPS (in the TSV group), but does not eliminate elevation in body temperature, 24 h after LPS injection. There was no significant difference in the hyperthermic phase between the TSV and sham-operated groups (Fig. 1B) .
In the third design, the LPS dose was increased to 1000 µg/kg. At this dose, LPS caused a similar febrile response in TSV and sham-operated rats (Fig. 1C) . In both groups, a biphasic febrile response exists and vagotomy did not cause febrile unresponsiveness when the pyrogen was administered at a higher dose.
Effect of LPS on HT PGE 2 production in vagotomized and sham-operated rats
HT PGE 2 production was significantly higher (P <0.05) in the sham-operated group, as compared to the TSV group, after LPS (500 µg/kg, i.p.) injection (Fig. 2) . Thus, vagotomy attenuated the increase in HT PGE 2 production in the vagotomized rats. On the other hand, vagotomy itself did not alter HT PGE 2 production in the saline-treated group (Fig. 2 , TSV+VEH versus SHAM+VEH). In this study, the administration of LPS to the sham-operated rats caused a significant decrease (P <0.01) in body temperature, 2 h after LPS injection, as compared to the vagotomized rats in which LPS did not lead to a significant decrease in body temperature (data not shown).
Changes in gastric weight in vagotomized rats
Gastric weight in vagotomized rats was significantly higher (P <0.01) than gastric weight in the sham-operated rats (Fig. 3) . No positive correlation between the magnitude of gastric enlargement and febrile unresponsiveness was found.
DISCUSSION
It has been well documented that vagus afferents are involved in the mediation of the peripheral-central 362 Azab, Kaplanski Fig. 1 . Dose-dependent effect of LPS on body temperature (°C) changes in vagotomized and sham-operated rats. In the first design (A) 200 µg/kg of LPS was administered (i.p.) to the TSV and sham-operated rats and body temperature was measured 0, 2, and 24 h post-injection. The control (sham-operated) group was injected with 0.5 ml of saline. In the second (B) and third (C) designs the same procedure was performed, but the LPS was administered at higher dosages (500 and 1000 µg/kg, respectively). For the first (A) and third (C) designs, the data shown express the (same) results of three independent experiments. The data regarding the second design (B) express the results of four independent experiments. Each column is the mean ± SEM for the sample size as indicated in parentheses. * P <0.05 versus SHAM+VEH, **P <0.05 versus SHAM+LPS. Fig. 3 . Effect of vagotomy on gastric weight in rats. Stomachs of vagotomized and sham-operated rats were removed (4 weeks postsurgery), cleaned and weighed. The figure expresses the (same) results of three independent experiments. Each column is the mean ± SEM for the sample size as indicated in parentheses. *P <0.01 versus sham-operated group.
Fig. 2.
Effect of vagotomy on ex vivo hypothalamic PGE 2 production at 2 h after LPS administration. TSV and sham-operated animals were treated with LPS (500 µg/kg, i.p.) or saline (0.5 ml/rat). PGE 2 production was expressed as its content in the incubation medium that accumulated within 1 h per weight of hypothalamus, as described earlier. The figure expresses the (same) results of three independent experiments. Each column is the mean ± SEM for the sample size as indicated in parentheses. *P <0.05 versus SHAM+VEH, **P <0.05 versus SHAM+LPS.
(G) communication. [3] [4] [5] [6] In experimental animals that underwent a subdiaphragmatic vagotomy, a febrile unresponsiveness (after a pyrogen administration) was found. This febrile unresponsiveness seems to be associated with vagotomy-induced interruption of the pathway of the pyrogenic signals. The involvement of the vagus in the mediation of the pyrogenic signal to the brain was (indirectly) reconfirmed when vagotomized rats were injected intracerebroventricularly with PGE 2 and their febrile response was similar to that of sham-operated animals. 11 The main purpose of the present study was to examine the relationship between the dosage of LPS and vagotomy-induced febrile unresponsiveness. This study was also intended to elucidate the effect of vagotomy on HT PGE 2 production. Our results clearly demonstrate that the effect of LPS on body temperature of vagotomized rats is dose-dependent. As shown in Figure 1A , a dose of 200 µg/kg (i.p.) of LPS did not lead to the usual biphasic febrile response in the vagotomized rats, as compared to the sham-operated rats. At the highest dose of the experimental protocol (1000 µg/kg), biphasic febrile response is present in both TSV and sham-operated animals. No vagotomy-attenuating effect on the pyrogenic effect of LPS was present, at such a high doses of LPS. In a study by Romanovsky et al., 4 it was found that vagotomy prevents the monophasic fever, caused by a low dose of the pyrogen (given intravenously), but it does not affect the biphasic febrile response caused by a moderate dose of LPS. Conversely, in the same report, 4 it was found that vagotomy enhances LPS-induced hypothermia in vagotomized rats. These contradicting findings may be explained by the different route of administration of the pyrogen (intravenous versus intraperitoneal in our study). In line with our findings, Kapas et al. 14 found that intraperitoneal injection of LPS (100 µg/kg) caused a biphasic febrile response that was attenuated in the vagotomized rats, as compared to the control rats. Furthermore, Sehic and Blatteis have shown that, in guinea pigs, vagotomy blocks the intravenous LPSinduced biphasic febrile response. 5 We are aware of the relatively high dosage of LPS given in our study. It is important to emphasize that, in this study, the pyrogen was given intraperitonealy, and under our experimental conditions, the dose of 200 µg/kg was optimal to cause a biphasic febrile response. The relationship between the dose/route of administration (of the pyrogen) and the effect of vagotomy on the febrile unresponsiveness has to be determined. However, it is important to stress that the present study demonstrates a dose-dependent effect of LPS on biphasic febrile response in vagotomized rats. It seems that with higher doses of LPS, the pyrogenic signal reaches the brain via accessory pathways, such as a passage through circumventricular organs (for example, the organum vasculosum laminae terminalis, OVLT) lacking the BBB. Furthermore, it was found that subdiaphragmatic vagotomy attenuates HT PGE 2 production, which was induced by LPS 500 µg/kg (Fig. 2 ). This decrease in HT PGE 2 production was accompanied with blockade of the hypothermic phase of the febrile response in the TSV group (data not shown). In this respect, it is important to emphasize that in a previous study, in which the effect of vagotomy on central levels of PGE 2 was examined, similar results were obtained. 5 In that study, PGE 2 levels were measured (by microdialysis) in the extracellular fluid of the POAH region of guinea pigs. In this study, HT PGE 2 was directly measured in the hypothalamic tissue, as previously described.
The so-called acute phase response, induced by LPS, includes the production of multiple cytokines. In our previous study, 15 we found that intraperitoneal administration of LPS (1 mg/kg) led to a pronounced elevation in plasma tumor necrosis factor-α (TNF-α), that peaked at 1 h after injection. Thereafter, it gradually decreased and after 3 h was hardly detectable. It was interesting to examine the effect of vagotomy, under the present experimental conditions, on LPS-induced elevation in plasma TNF-α. In two independent experiments, in which plasma levels of TNFα were determined by ELISA, we found similar results in the vagotomized and sham-operated animals (data not shown). These results may be related to the timing of plasma collection, since it was performed at 120-125 min after LPS injection (when hypothermia exists). In these experiments, plasma levels of IL-1β were also determined by ELISA, and similar results were obtained in both vagotomized and sham-operated groups (data not shown). Nevertheless, in a previous study by Hansen et al., 7 it was found that vagotomy has no marked effect on blood levels of IL-1β, IL-6 and corticosterone. In this regard, it is worth noting that vagal efferents are important counter-regulators of LPS-induced cytokine synthesis. 16 It was found that acetylcholine (ACh) dose-dependently inhibited LPSinduced release of TNF-α, IL-1β, IL-6 and IL-18, in human macrophage cultures. This inhibitory effect of ACh on cytokine release was mediated primarily by nicotinic ACh receptors. 16 It was also found that bilateral cervical vagotomy (efferents), significantly increased peak serum and hepatic TNF-α amounts, in rats treated with a lethal dose of LPS (15 mg/kg, intravenously). The development of endotoxin-induced hypotension (septic shock), which accompanied the significant increase in TNF-α release in the vagotomized (efferents) rats, was significantly attenuated by electrical stimulation of the distal ends of the resected nerves. Taken together, these results indicate a 'cholinergic anti-inflammatory pathway'. 16 Whether the vagotomy-induced elevation in serum and hepatic amounts of TNF-α, which was demonstrated in this study, 16 may provide at least a partial explanation for the fever that occurs in humans who have vagotomies for liver transplants, remains to be ascertained.
It is well recognized that vagotomy affects feeding behavior and causes gastric enlargement. 6, [17] [18] [19] We examined the effect of vagotomy on gastric weight, paying special attention to the relationship between the magnitude of gastric enlargement and the febrile unresponsiveness. It is important to emphasize that in some previous studies, 6, 19 the existence of gastric enlargement was accepted as confirming the completeness of vagotomy. It was found (Fig. 3 ) that the stomachs of TSV animals were heavier than those of sham-operated animals. Vagotomy-induced gastric enlargement is associated with delayed gastric emptying and pylorus constriction; the addition of pyloroplasty eliminated the gastric distention in vagotomized rats. 17 Nevertheless, no positive correlation between the magnitude of gastric enlargement and the febrile unresponsiveness was found.
CONCLUSIONS
In vagotomized rats, LPS induces changes in body temperature in a dose-dependent manner. We found that vagotomy attenuates LPS-induced increase in hypothalamic PGE 2 . This may cast further light on the crucial role played by the vagal afferents -as a peripheral-central pathway -in the mediation of the febrile response.
